Factors driving global demand for DNA vaccine market are increasing awareness amongst health professional, fewer side effects, ease of development and lower cost, constant progress in biotechnology and conventional therapy failure in treatment of most infectious diseases.
This report provides information on DNA vaccine market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to DNA vaccine market.
Globally, emerging technologies have taken healthcare closer to patients, DNA vaccines is one among these technology. They mainly use immunological pathways, which are difficult to achieve by other technologies. North America, Europe and other developed economies have good market for DNA vaccines due to their well-equipped healthcare infrastructure, a prominent research and development activities in the field of DNA vaccines, awareness among healthcare physicians on treatment options and percentage of people covered under healthcare insurance. APAC region has a growing demand for DNA vaccines due to increasing awareness on availability of new treatment options and increased focus on research and development activities.
This report identifies global DNA vaccine market based on different types and regional market as follows:
DNA vaccine market is segmented based on types. There are two main types’ human DNA vaccines and animals DNA vaccines, there are more than 100 products under clinical trial for different diseases in humans including HIV infection, cancer and infectious diseases etc. and three animal DNA vaccines are approved for veterinary use
This report is further segmented based on potential markets for DNA vaccines. A detailed analysis by region – United States, Europe, Asia-Pacific (APAC) and Rest of the World (RoW), has been provided in this report
This report looks into all the major companies operating in the DNA vaccines. Some of the major companies’ profiles are as follows:
Inovio Biomedical Corp.
Merck & Co.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. DNA Vaccines - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. DNA Vaccines - Market Forces
4.1.1. Growing interest towards DNA vaccines as treatment option
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Customers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. DNA Vaccines Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. DNA Vaccines Market, By type
6.1. DNA vaccines for humans
6.2. DNA vaccines for animals
7. DNA Vaccines Market, By Geography
7.2. North America
7.3.6. Rest of Europe
7.4. Asia Pacific
7.4.2. South Korea
7.4.5. Rest of Asia Pacific
8. Market Entropy
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
9.1. Inovio Biomedical Corp.
9.2. Merck & Co.
9.3. Mitsubishi Tanabe
9.4. Dendreon Corporation
9.5. ASTELLAS PHARMA
9.6. Dynavax Technologies
9.8. Tekmira Pharmaceuticals
9.9. GlaxoSmithKline Corp.
9.10. Protein Sciences Corp.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.4. Expert Insights